Prediction of diltiazem plasma concentration curves from limited measurements using compliance data.
about
Drugs for preventing red blood cell dehydration in people with sickle cell diseaseDrugs for preventing red blood cell dehydration in people with sickle cell diseaseDrugs for preventing red blood cell dehydration in people with sickle cell diseaseIdentification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis.Lazy sunday afternoons: the negative impact of interruptions in patients' daily routine on adherence to oral antidiabetic medication. A multilevel analysis of electronic monitoring data.Projected inhibition of platelet aggregation with ticagrelor twice daily vs. clopidogrel once daily based on patient adherence data (the TWICE project).Successful projection of the time course of drug concentration in plasma during a 1-year period from electronically compiled dosing-time data used as input to individually parameterized pharmacokinetic models.Improving medication adherence in diabetes type 2 patients through Real Time Medication Monitoring: a randomised controlled trial to evaluate the effect of monitoring patients' medication use combined with short message service (SMS) reminderse-Monitoring of Asthma Therapy to Improve Compliance in children using a real-time medication monitoring system (RTMM): the e-MATIC study protocol.An examination of 1-year adherence and persistence rates to antiepileptic medication in children with newly diagnosed epilepsyPharmacokinetic and pharmacodynamic data and models in clinical trials.Do we need full compliance data for population pharmacokinetic analysis?Association between adherence measurements of metoprolol and health care utilization in older patients with heart failure.Use of a Novel Artificial Intelligence Platform on Mobile Devices to Assess Dosing Compliance in a Phase 2 Clinical Trial in Subjects With Schizophrenia.Non-vitamin K antagonist oral anticoagulants: considerations on once- vs. twice-daily regimens and their potential impact on medication adherence.Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories.The association of ethnicity with electronically measured adherence to inhaled corticosteroids in children.Bayesian population modeling of drug dosing adherence.Feasibility of Real Time Medication Monitoring Among HIV Infected and TB Patients in a Resource-Limited Setting.Estimation of the impact of noncompliance on pharmacokinetics: an analysis of the influence of dosing regimens."White coat compliance" limits the reliability of therapeutic drug monitoring in HIV-1-infected patients.Methods for measuring, enhancing, and accounting for medication adherence in clinical trials.Compliance spectrum as a drug fingerprint of drug intake and drug disposition.
P2860
Q24186046-415DB7CE-6C9A-43E0-B49F-09C787BB9BE4Q24202032-0C96D0F8-DA6D-4568-A3F0-C9DD073E3F67Q24240777-DAD64B08-1907-436E-8A4C-E458632ECCE2Q30539620-4A327F78-0662-491A-AD02-B8C1396BFA4CQ30616953-6F4EF080-DB73-4FB1-8806-3AA4D4162300Q30827217-8646B642-AFA6-467C-8CA2-6CD126ECE093Q30985350-D5B6D8DC-E634-44B7-B623-30BEFF96085BQ33789527-E74B6AD9-4B9A-432A-975D-C3E6053BD6FAQ34628486-944E8E7E-25FD-4434-96D7-295C83721529Q34884914-E9EEF6BB-5176-4911-AB36-CDAEEBB1F9B0Q36765400-62B08A7B-DA0B-4785-947C-B184F33707C0Q36838558-8695BB32-8843-4CC8-9A7B-6D5BCE7E21E1Q36958657-57407C79-CE71-4E8D-B201-6C2FE9CBB60DQ37685657-3F460269-B16B-4D15-A5A9-31BA8417D71AQ38361014-F66980B1-0E6E-4429-A1C7-41A1891E03BFQ38426541-359DE83C-977E-40AB-8637-EB2960516052Q39554792-0FFA840F-BFA6-4FA3-B308-EA096ADF4874Q40594262-9D0262DF-75A3-4239-9F0E-418693B49454Q40896330-5E09F6DC-2E2C-456F-B5E6-E1317E29B71DQ40943722-A6E29DBD-82B0-4BF4-8596-22EA128A70DAQ43420406-F21055B0-CCEE-47D8-9EF0-C8B1F0F6F97EQ46630774-3789EE0A-1A21-4977-ADF1-7CC40A3E772CQ51286554-DD3FEBF6-E965-4D3D-A6FA-D20C96A3E339
P2860
Prediction of diltiazem plasma concentration curves from limited measurements using compliance data.
description
1992 nî lūn-bûn
@nan
1992 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի մարտին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Prediction of diltiazem plasma ...... rements using compliance data.
@ast
Prediction of diltiazem plasma ...... rements using compliance data.
@en
type
label
Prediction of diltiazem plasma ...... rements using compliance data.
@ast
Prediction of diltiazem plasma ...... rements using compliance data.
@en
prefLabel
Prediction of diltiazem plasma ...... rements using compliance data.
@ast
Prediction of diltiazem plasma ...... rements using compliance data.
@en
P2093
P1476
Prediction of diltiazem plasma ...... rements using compliance data.
@en
P2093
P304
P356
10.2165/00003088-199222030-00006
P577
1992-03-01T00:00:00Z
P6179
1026717666